Joint Authority for Päijät-Häme Social and Health Care
Quick facts
Marketed products
- BF-200 ALA cream · Dermatology/Oncology
BF-200 ALA cream is a photodynamic therapy agent that uses aminolevulinic acid to generate reactive oxygen species upon light activation, destroying abnormal skin cells. - Methyl 5-aminolevulinate
- Methylaminolevulinate cream
Phase 1 pipeline
- Aminolevulinic Acid Nano Emulsion
- Hexylaminolaevulinate cream
- Hexylaminolevulinate cream
- Methylaminolaevulinate cream
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Joint Authority for Päijät-Häme Social and Health Care portfolio CI brief
- Joint Authority for Päijät-Häme Social and Health Care pipeline updates RSS
Frequently asked questions about Joint Authority for Päijät-Häme Social and Health Care
What are Joint Authority for Päijät-Häme Social and Health Care's marketed drugs?
Top marketed products include BF-200 ALA cream, Methyl 5-aminolevulinate, Methylaminolevulinate cream.
Related
- BF-200 ALA cream · Dermatology/Oncology
- Methyl 5-aminolevulinate
- Methylaminolevulinate cream
- Sector hub: All tracked pharma companies